In Response to Fogarty Et Al. And Why Adjuvant Whole Brain Radiotherapy Is Not Recommended Routinely

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3672-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search